Inhibition of glutathione S-transferase activity in human melanoma cells by α,β-unsaturated carbonyl derivatives. Effects of acrolein: Cinnamaldehyde, citral, crotonaldehyde, curcumin, ethacrynic acid, and trans-2-hexenal

Chemico-Biological Interactions

Volumn 102, Issue 2, 1996, Pages 117-132

  Van Iersel, Marlou L P S ^a   Ploemen, Jan Peter H T M ^b   Struik, Isabelle ^a   Van Amersfoort, Chris ^a   Keyzer, Annelies E ^b   Schefferlie, Johan G ^b   Van Bladeren, Peter J ^a,b  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b TNO   (Netherlands)

Author keywords

Aldehydes; Cells; Glutathione S transferases; Inhibition; Ketones

Indexed keywords

2 HEXENAL; ACROLEIN; CINNAMALDEHYDE; CITRAL; CROTONALDEHYDE; CURCUMIN; ETACRYNIC ACID; GLUTATHIONE TRANSFERASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MELANOMA CELL;

ACROLEIN; ALDEHYDES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CURCUMIN; ENZYME INHIBITORS; ETHACRYNIC ACID; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HUMANS; MELANOMA; MONOTERPENES; SKIN NEOPLASMS; TERPENES; TUMOR CELLS, CULTURED;

EID: 0030597060     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(96)03739-8     Document Type: Article

References (44)

1. [1] B. Mannervik and U.H. Danielson, Glutathione S-transferases -Structure and catalytic activity, Crit. Rev. Biochem. Mol. Biol., 23 (1988) 283-337.
2. [2] J.H.T.M. Ploemen, B. van Ommen, M.L.P.S. van Iersel, C.J.M. Rompelberg, H. Verhagen and P.J. van Bladeren, Irreversible inhibition of cytosolic glutathione S-transferase, in: N.P.E. Vermeulen, G.J. Mulder, H. Nieuwenhuyse, W.H.M. Peters and P.J. van Bladeren (Eds.), Glutathione S-transferases: Structure, Functions and Clinical Applications, Taylor and Francis, London, (1996) 143-153.
3. [3] B. Mannervik, The isoenzymes of glutathione transferase, Adv. Enzym. Rel. Areas Mol. Biol., 57 (1985) 357-417.
4. [4] D.J. Waxman, Glutathione S-transferases: role in alkylating agent resistance and possible target for modulation chemotherapy - a review, Cancer Res., 50 (1990) 6449-6454.
5. [5] S.M. Black and C.R. Wolf, The role of glutathione-dependent enzymes in drug resistance, Pharmacol. Therap., 51 (1991) 139-154.
6. [6] S. Ouwerkerk-Mahadevan, J.H. van Boom, M.C. Dreef-Tromp, J.H.T.M. Ploemen, D.J. Meyer and G.J. Mulder, Glutathione analogues as novel inhibitors of rat and human glutathione S-transferase isoenzymes, as well as of glutathione conjugation in isolated rat hepatocytes and the rat in vivo, Biochem. J., 308 (1995) 283-290.
7. [7] A.S. Morgan, P.J. Ciaccio, K.D. Tew and L.M. Kauvar, Isoenzyme-specific glutathione S-transferase inhibitors potentiate drug sensitivity in cultured human tumor cell lines, Cancer Chemother. Pharmacol., 37 (1996) 363-370.
8. [8] J.T. Ahokas, F.A. Nicholls, P.J. Ravenscroft and B.T. Emmerson, Inhibition of purified rat liver glutathione S-transferase isoenzymes by diuretic drugs, Biochem. Pharmacol., 34 (1985) 2157-2161.
9. [9] J.H.T.M. Ploemen, B. van Ommen and P.J. van Bladeren, Inhibition of rat and human glutathione S-transferase isoenzymes by ethacrynic acid and its glutathione conjugate, Biochem. Pharmacol., 40 (1990) 1631-1635.
10. [10] J.H.T.M. Ploemen, J.J.P. Bogaards, G.A. Veldink, B. van Ommen, D.H.M. Jansen and P.J. van Bladeren, Isoenzyme selective irreversible inhibition of rat and human glutathione S-transferases by ethacrynic acid and two brominated derivatives, Biochem. Pharmacol., 45 (1993) 633-639.
11. [11] J. Hansson, K. Berhane, V.M. Castro, U. Jungnelius, B. Mannervik and U. Ringborg, Sensitization of human melanoma cells to the cytotoxic effect of melphalan by the glutathione transferase inhibitor ethacrynic acid, Cancer Res., 51 (1991) 94-98.
12. [12] P.J. O'Dwyer, F. LaCreta, S. Nash, P.W. Tinsley, R. Schilder, M.L. Clapper, K.D. Tew, L. Panting, S. Liwin, R.L. Comis and R.F. Ozols, Phase I study of thiotepa in combination with glutathione transferase inhibitor ethacrynic acid, Cancer Res., 51 (1991) 6059-6065.
13. [13] K.D. Tew, A.M. Bomber and S.J. Hoffman, Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines, Cancer Res., 48 (1988) 3622-3625.
14. [14] T. Rhodes and P.R. Twentyman, A study of ethacrynic acid as a potential modifier of melphalan and cisplatin sensitivity in human lung cancer parental and drug-resistant cell lines, Br. J. Cancer, 65 (1992) 684-690.
15. [15] S.V. Singh, B.H. Xu, A.K. Maurya and A.M. Mian, Modulation of mitomycin C resistance by glutathione transferase inhibitor ethacrynic acid, Biochim. Biophys. Acta, 1137 (1992) 257-263.
16. [16] K.D. Tew, Glutathione-associated enzymes in anti-cancer drug resistance, Cancer Res., 54 (1994) 4313-4320.
17. [17] K. Berhane and B. Mannervik, Inactivation of the genotoxic aldehyde acrolein by human glutathione transferases of classes α, μ, and π, Mol. Pharmacol., 37 (1990) 251-254.
18. [18] C.I. Chien, K.S. Kirollos, R.J. Linderman and W.C. Dauterman, α,β-Unsaturated carbonyl compounds: inhibition of rat liver glutathione S-transferase isozymes and chemical reaction with reduced glutathione, Biochim. Biophys. Acta, 1204 (1994) 175-180.
19. [19] C. Ramachandran, Z.K. Yuan, X.L. Huang and A. Krishan, Doxorubicin resistance in human melanoma cells: MDR-1 and glutathione S-transferase π gene expression, Biochem. Pharmacol., 45 (1993) 743-751.
20. [20] M. Sokolovsky, T. Sadeh and A. Patchornik, Specific chemical cleavage of cysteinyl peptides, J. Am. Chem. Soc., 86 (1964) 1212-1217.
21. [21] D.B. Mitchell, K.S. Santone and D. Acosta, Evaluation of cytotoxicity in cultured cells by enzyme leakage, J. Tissue Culture Methods, 6 (1980) 113-116.
22. [22] P.J. Hissin and R. Hilf, A fluorometric method for determination of oxidized and reduced glutathione in tissues, Anal. Biochem., 74 (1976) 214-226.
23. [23] M. Bradford, A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 72 (1976) 248-254.
24. [24] W.H. Habig, M.J. Pabst and W.B. Jakoby, Glutathione S-transferases, The first step in mercapturic acid formation. J. Biol. Chem., 249 (1974) 7130-7139.
25. [25] B. Mannervik and C. Guthenberg, Glutathione transferase (human placenta), Methods Enzymol., 77 (1981) 231-235.
26. [26] J.J.P. Bogaards, B. van Ommen and P.J. van Bladeren, An improved method for the separation and quantification of glutathione S-transferase subunits in rat tissue using high-performance liquid chromatography, J. Chromatogr., 474 (1989) 435-440.
27. [27] B. van Ommen, J.J.P. Bogaards, W.H.M. Peters, B. Blaauboer and P.J. van Bladeren, Quantification of human hepatic glutathione S-transferases, Biochem. J., 269 (1990) 609-613.
28. [28] P.J. Oude Elferink, R. Ottenhoff, W. Liefting, J. de Haan and P.L.M. Jansen, Hepatobiliary transport of glutathione and glutathione conjugate in rats with hereditary hyperbilirubinemia, J. Clin. Invest., 84 (1989) 476-483.
29. [29] G. Lindwall and T.D. Boyer, Excretion of glutathione conjugates by primary cultured rat hepatocytes. J. Biol. Chem., 262 (1987) 5151-5158.
30. [30] A. Meister, Metabolism and transport of glutathione and other δ-glutamyl compounds, in: A. Larsson, S. Orrenius, A. Holmgrenand and B. Mannervik (Eds.), Functions of Glutathione: Biochemical, Physiological, Toxicological and Clinical Aspects, Raven Press, New York, 1983, pp. 1-22.
31. [31] G. Witz, Biological interactions of αβ-unsaturated aldehydes, Free Radic. Biol. Med., 7 (1989) 333-349.
32. [32] H. Esterbauer, R.J. Schaur and H. Zollner, Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes, Free Radic. Biol. Med., 11 (1991) 81-128.
33. [33] A. Desideri, A.M. Caccuri, F. Polizio, R. Bastoni and G. Federici, Electron paramagnetic resonance identification of a highly reactive thiol group in the proximity of the catalytic site of human placenta glutathione transferase, J. Biol. Chem., 266 (1991) 2063-2066.
34. [34] K. Tamai, H. Satoh, S. Tsuchida, I. Hatayama, T. Maki and H. Sato, Specific inactivation of glutathione S-transferases in class π by SH-modifiers, Biochem. Biophys. Res. Comm., 167 (1990) 331-338.
35. [35] E. Schauenstein, M. Taufer, H. Esterbauer, A. Kylianek and Th. Seelich, The reaction of protein-SH-groups with 4-hydroxy-pentenal, Monatsh. Chem., 102 (1971) 517-529.
36. [36] J.H.T.M. Ploemen, A. van Schanke, B. van Ommen and P.J. van Bladeren, Reversible conjugation of ethacrynic acid with glutathione and human glutathione S-transferase P1-1, Cancer Res., 54 (1994) 915-919.
37. [37] T. Ishikawa. The ATP-dependent glutathione S-conjugate export pump. Trends Biochem. Sci., 17 (1992) 463-468.
38. [38] M. Müller, C. Meijer, G.J. Zaman, P. Borst, R.J. Scheper and N.H. Mulder, Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport, Proc. Natl. Acad. Sci. USA, 91 (1994) 13033-13037.
39. [39] T. Ishikawa, K. Akimaru, M.T. Kuo, W. Priebe and M. Suzuki, How does the MRP/GS-X pump export doxorubicin?, J. Natl. Cancer Inst., 87 (1995) 1639-1640.
40. [40] K. Kobayashi, Y. Sogame, H. Hara and K. Hayashi, Mechanism of glutathione S-conjugates transport in canalicular and basolateral rat liver plasma membranes, J. Biol. Chem., 265 (1985) 7737-7741.
41. [41] T.P.M. Akerboom, V. Narayanaswami, M. Kunst and H. Sies, ATP-dependent S-(2,4-dinitrophenyl)glutathione transport in canalicular plasma membrane vesicles from rat liver, J. Biol. Chem., 266 (1991) 13147-13152.
42. [42] C. Olive and P. Board, Glutathione S-conjugate transport by cultured cells, Biochim. Biophys. Acta, 1224 (1994) 264-268.
43. [43] S. Oetari, M. Sudibyo, J.N.M. Commandeur, R. Samhoedi and N.P.E. Vermeulen, Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver, Biochem. Pharmacol., 51 (1996) 39-45.
44. [44] S. Kuzmich, L.A. Vanderveer, E.S. Walsh, F.P. LaCreta and K.D. Tew, Increased levels of glutathione S-transferase π transcript as a mechanism of resistance to ethacrynic acid, Biochem. J., 281 (1992) 219-224.